Accessibility Menu
Hyperfine logo

Hyperfine(NASDAQ) HYPR

Market Cap$92.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2021)-91%
5 Year-91%
1 Year-12%
1 Month-30%
$0.98
+4.70%
+0.04Today
After hours$0.98+$0.00 (+0.25%)
Hyperfine last closing stock price
MetricPriceDate
Last closeUSD 0.942026-07-31
Hyperfine stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.9%USD 0.952026-07-24
1 month-30.16%USD 1.342026-07-01
3 month-49.96%USD 1.872026-05-01
Year to date-4.44%USD 0.982025-12-31
1 year-11.72%USD 1.062025-07-31
3 year-66.93%USD 2.832023-08-01
5 year-90.54%USD 9.892021-07-30
Since inception-90.65%USD 10.012021-01-27

Hyperfine Financials at a Glance

Market Cap

$92.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$15.33M

Net Income (TTM)

-$34.78M

EPS (TTM)

-$0.41

P/E Ratio

-2.29

Dividend

$0.00

Beta (Volatility)

1.35 (Average)

Price

$0.98

Volume

403,030

Open

$0.94

Previous Close

$0.98

Daily Range

$0.94 - $1.02

52-Week Range

$0.85 - $2.22

Estimated Earnings Date

Aug 6, 2026

HYPR News

featured-earnings-leadership-highlights.png

Hyperfine Q2 Revenue Jumps 26 Percent

Motley Fool Markets TeamAug 14, 2025
Foolcom-Featured.png

Hyperfine Posts Higher Margin in Q2

Motley Fool Markets TeamAug 13, 2025

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Hyperfine

Hyperfine makes portable MRI scanners for hospitals and clinics. Its devices help doctors quickly scan patients at the bedside. This technology aims to make brain imaging more accessible and efficient for all ages.

Gadgets That Scan: Products and Services

  • Swoop Portable MRI: Mobile brain scanner for hospitals, clinics, and offices; enables bedside imaging for all ages.
  • Optive AI Software: Artificial intelligence platform that improves image quality and reduces scan time; used with Swoop system.
  • Service & Support (15.9% of revenue): Annual contracts for hardware maintenance, software updates, and cloud image storage.
  • PULSE Platform: Subscription service for research and data sharing among Swoop users.

Growth Moves: Expansion and Strategy

  • Launched next-generation Swoop scanner with new AI software in mid-2025.
  • Entered neurology office market after accreditation pilot in late 2024–mid-2025.
  • Expanded internationally with regulatory approvals in the EU, UK, India, Canada, Australia, and New Zealand (2024–2025), and formed distributor partnerships in the Middle East.
  • Secured grant funding from the Bill & Melinda Gates Foundation for global health projects.
  • Formed new distributor partnerships for global sales in 2025.

Why Hyperfine Catches the Eye

Hyperfine’s portable MRI system works in places where traditional scanners cannot fit. Its AI software helps doctors get faster, clearer images. The company’s direct sales and distributor model supports both U.S. and global growth.

Five Things You Need to Know

  • Total revenue was $13.6 million in 2025, up 5.2% from 2024.
  • Device sales made up 84.1% of revenue in 2025; service sales were 15.9%.
  • Gross margin improved to 50.2% in 2025, down from 54.3% in 2024.
  • International sales were 23% of revenue in 2025, with 77% from the U.S.

Bottom Line

Hyperfine has shifted brain imaging from fixed rooms to the patient’s bedside. Its portable MRI and AI tools support a growing, global healthcare market.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

102

CEO

Maria Degois Sainz

Website

www.hyperfine.io

Headquarters

Guilford, CT 06437, US

HYPR Financials

Key Financial Metrics (TTM)

Gross Margin

51.20%

Operating Margin

-226.64%

Net Income Margin

-226.88%

Return on Equity

-101.28%

Return on Capital

-89.75%

Return on Assets

-57.64%

Earnings Yield

-43.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$92.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

99.27M

Volume

403.03K

Avg. Volume

1.02M

Financials (TTM)

Gross Profit

$7.85M

Operating Income

-$34.74M

EBITDA

-$33.15M

Operating Cash Flow

-$27.71M

Capital Expenditure

-$955.00K

Free Cash Flow

-$28.66M

Cash & ST Invst.

$40.78M

Total Debt

$13.35M

Hyperfine Performance Analysis

Hyperfine annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 6,814,000355.5%
20232023-12-31USD 11,032,00061.9%
20242024-12-31USD 12,890,00016.8%
20252025-12-31USD 13,563,0005.2%
Hyperfine sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3026.2%
Q32025-09-3027.5%
Q42025-12-3154.0%
Q12026-03-31-26.3%
Hyperfine annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -1.0412.6%
20232023-12-31USD -0.62-40.3%
20242024-12-31USD -0.56-9.4%
20252025-12-31USD -0.43-22.7%
Hyperfine sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-30N/A
Q32025-09-30-16.7%
Q42025-12-3155.1%
Q12026-03-31-43.3%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$3.90M

+82.6%

Gross Profit

$1.98M

+124.1%

Gross Margin

50.70%

N/A

Market Cap

$92.90MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$910.76K

N/A

Employees

102

N/A

Net Income

-$8.62M

+8.4%

EBITDA

-$8.27M

+10.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$40.78M

+23.2%

Total Debt

$13.35M

+4976.8%

Accounts Receivable

$5.80M

-20.2%

Inventory

$6.33M

+36.4%

Long Term Debt

$13.14M

N/A

Short Term Debt

$229.00K

-12.9%

Return on Assets

-57.64%

N/A

Return on Invested Capital

-69.23%

N/A

Free Cash Flow

-$9.25M

+4.8%

Operating Cash Flow

-$9.01M

+2.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
LUNGPulmonx Corporation
$2.12+30.06%
VANIVivani Medical, Inc.
$1.33+3.91%
RCELAvita Medical Inc.
$4.62+5.00%
FONRFonar Corp.
$19.09+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SQQQProShares Trust - ProShares UltraPro Short Qqq
$41.43-0.05%
NVDANvidia
$206.64+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.81+0.07%
INTCIntel
$91.00+0.01%

Questions About HYPR

What is the current price of Hyperfine?

Hyperfine is trading at $0.98 per share.

What is the 52-week range for Hyperfine?

Over the past 52 weeks, Hyperfine has traded between $0.85 and $2.22.

How much debt does Hyperfine have?

As of the most recent reporting period, Hyperfine reported total debt of $13.37M.

How much cash does Hyperfine have on hand?

Hyperfine reported $41.28M in cash and cash equivalents in its most recent financial results.

What is Hyperfine’s dividend yield?

Hyperfine does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services